Subscribe to Times Africa Login

Login EPL digital page
Subscribe to Times Africa Login How to use a digital package? | Site Flip client | Create an account
Digital Package Bookings |
The digital read-page paper used to activate an order received from a reader of code. Find a sheet of paper tellimisarvelt personal code reader (in the absence of the code reader to contact customer service). Go to page http://www.digilehed.ee/lugejakood Log in to an existing account or absence of a digital story of the new digital account. Enter the code reader in the provided field. Verify your information and follow the instructions to start reading. Registration Code Reader is a one-time process. Next login you will gain access automatically.
Companies
Ardo Kaljuvee
2005th was held in May of America Clinical Oncology's (ASCO) population of charlotte nc reunion population of charlotte nc - the world's largest cancer researchers population of charlotte nc and healer visitation - which might have noticed a slight excitement in breast cancer specialists. Just this year, a study published results, which may significantly change the treatment of breast cancer patients. Good news related to the so-called-targeted drugs, i.e. therapeutic targeting of specific gene products (proteins), and other factors influencing the growth of tumor cells. This treatment method is based on the understanding that all breast cancer cases are not identical.
In fact, researchers have long observed that breast cancer does not behave the same way in different people: some women can help traditional treatments, some do not. However, it has begun to understand the disease at the molecular level only recently population of charlotte nc received and understand that it is in fact a number of different diseases.
The new approach will allow the future to find the right balance for each patient treatment. It also adds to the hope that further progress should be followed by more and faster because it is now the development has already begun and resources available.
The diagnosis population of charlotte nc of breast cancer affects a patient will undoubtedly always be intimidating, but it is already possible to imagine a time when the chest piece, finding a doctor or the words "You have breast cancer" does not cause women to more such horror as years ago.
A large part of the 2005th ASCO annual meeting in the excitement occurred was related to trastuzumab, - a drug which is intended to operate at excessively HER2 (human epidermal growth factor receptor 2), breast cancer cells by producing a protein named. Patients with breast cancer, produces an excess of the HER2 protein, referred to as HER2 positive, and the prognosis of the disease population of charlotte nc is usually poor, even in the implementation of chemotherapy. About 25% of all breast cancers overexpress HER2 occurs.
This medicine was 1998th in approved system for use with those of HER2-positive women whose breast cancer has spread to the body (metastasize). It comes from the influence population of charlotte nc of each patient though, but if it is effective, the results can be very good. In some cases, the tumor has completely disappeared. Due to the success of the drug for the treatment of advanced cancer of the research on the newly launched (HER2-positive) breast cancer diagnosed in women. Two results of a study presented at the 2005th ASCO annual reunion in one session, which some participants later characterized as "an innovative treatment population of charlotte nc to alter the tactics." Boston's Dana Farber Cancer Institute, breast cancer, the practicing population of charlotte nc physician and researcher Dr. Harold Burstein argued that there was a study which could immediately tell by looking at the data, the result is obvious, and the sick should be able to handle this medicine.
The results showed that the addition of the drug to a standard chemotherapy treatment for breast cancer reduced the re-formation of 52%, when compared to patients receiving chemotherapy alone. Investigators do not know yet though if the medicine works best when given during population of charlotte nc or after chemotherapy. But there's no doubt that it should be used in first-line treatment of metastatic cancer, population of charlotte nc and not only. One unanswered question so far has been linked to heart problems that arise in 3-4% of women who are taking the drug